RNA: packaged and protected by VLPs
- PMID: 35539947
- PMCID: PMC9080931
- DOI: 10.1039/c8ra02084a
RNA: packaged and protected by VLPs
Abstract
Virus Like Particles (VLPs) are devices for RNA packaging, protection and delivery, with utility in fundamental research, drug discovery, and disease treatment. Using E. coli for combined expression and packaging of non-viral RNAs into Qβ VLPs, we investigated the extent of chemical protection conferred by packaging of RNA in VLPs. We also probed relationships between packaging efficiency and RNA size, sequence and intrinsic compaction. We observe that VLP packaging protects RNA against assault by small diffusible damaging agents such as hydroxyl radicals and divalent cations. By contrast, the extent of unmediated cleavage, in the absence of reactive species, is the same for RNA that is free or packaged within VLPs, and is very slow. In vivo packaging of RNA within VLPs appears to be more efficient for intrinsically compact RNAs, such as rRNA, and less efficient for unstructured, elongated RNA such as mRNA. Packaging efficiency is reduced by addition of the ribosome binding site to a target RNA. The Qβ hairpin is necessary but not sufficient for efficient packaging.
This journal is © The Royal Society of Chemistry.
Conflict of interest statement
There are no conflicts to declare.
Figures





Similar articles
-
Functional RNAs: combined assembly and packaging in VLPs.Nucleic Acids Res. 2017 Apr 7;45(6):3519-3527. doi: 10.1093/nar/gkw1154. Nucleic Acids Res. 2017. PMID: 27903913 Free PMC article.
-
Mutations in the alpha-helical region of the amino terminus of the Maize rayado fino virus capsid protein and CP:RNA ratios affect virus-like particle encapsidation of RNAs.Virus Res. 2015 Jan 22;196:70-8. doi: 10.1016/j.virusres.2014.07.033. Epub 2014 Aug 5. Virus Res. 2015. PMID: 25102332
-
BPV1 E2 protein enhances packaging of full-length plasmid DNA in BPV1 pseudovirions.Virology. 2000 Jul 5;272(2):382-93. doi: 10.1006/viro.2000.0348. Virology. 2000. PMID: 10873782
-
Determinants of Genomic RNA Encapsidation in the Saccharomyces cerevisiae Long Terminal Repeat Retrotransposons Ty1 and Ty3.Viruses. 2016 Jul 14;8(7):193. doi: 10.3390/v8070193. Viruses. 2016. PMID: 27428991 Free PMC article. Review.
-
Murine polyomavirus virus-like particles (VLPs) as vectors for gene and immune therapy and vaccines against viral infections and cancer.Anticancer Res. 2005 Jul-Aug;25(4):2601-8. Anticancer Res. 2005. PMID: 16080500 Review.
Cited by
-
Development of SARS-CoV-2 packaged RNA reference material for nucleic acid testing.Anal Bioanal Chem. 2022 Feb;414(5):1773-1785. doi: 10.1007/s00216-021-03846-y. Epub 2021 Dec 27. Anal Bioanal Chem. 2022. PMID: 34958396 Free PMC article.
-
Virus-inspired strategies for cancer therapy.Semin Cancer Biol. 2022 Nov;86(Pt 3):1143-1157. doi: 10.1016/j.semcancer.2021.06.021. Epub 2021 Jun 26. Semin Cancer Biol. 2022. PMID: 34182141 Free PMC article. Review.
-
Proof of concept for a single-dose Group B Streptococcus vaccine based on capsular polysaccharide conjugated to Qβ virus-like particles.NPJ Vaccines. 2023 Oct 6;8(1):152. doi: 10.1038/s41541-023-00744-5. NPJ Vaccines. 2023. PMID: 37803013 Free PMC article.
-
Effective removal of host cell-derived nucleic acids bound to hepatitis B core antigen virus-like particles by heparin chromatography.Front Bioeng Biotechnol. 2024 Oct 3;12:1475918. doi: 10.3389/fbioe.2024.1475918. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 39431243 Free PMC article.
-
Effects of Different Lengths of a Nucleic Acid Binding Region and Bound Nucleic Acids on the Phase Behavior and Purification Process of HBcAg Virus-Like Particles.Front Bioeng Biotechnol. 2022 Jul 1;10:929243. doi: 10.3389/fbioe.2022.929243. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35845397 Free PMC article.
References
-
- Goodchild J., in Therapeutic Oligonucleotides, Springer, 2011, pp. 1–15 - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources